These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19026826)

  • 21. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lyons G; Quadrelli S; Jordan P; Colt H; Chimondeguy D
    Lung Cancer; 2011 Nov; 74(2):244-7. PubMed ID: 21411177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of treatment and future diagnosis of early non-small cell lung carcinoma.
    Banks SB; Rose DM; Moore JM; Kline AL
    Curr Surg; 2003; 60(2):199-203. PubMed ID: 14972296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after resection of synchronous bilateral lung cancer.
    De Leyn P; Moons J; Vansteenkiste J; Verbeken E; Van Raemdonck D; Nafteux P; Decaluwe H; Lerut T
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1215-22. PubMed ID: 18829338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNM stage is the most important determinant of survival in metachronous lung cancer.
    Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
    Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The validity and problems of a new staging system for lung cancer from the point of view of surgical results].
    Watanabe A; Tabata A; Ingu A; Watanabe T; Ichimiya Y; Kusajima K; Abe T; Abe S; Satoh M
    Kyobu Geka; 2000 Oct; 53(11):929-32. PubMed ID: 11048444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
    Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
    Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lung cancer: new staging system and prognosis].
    Li C; Zhang R
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):189-91. PubMed ID: 11832024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer.
    Collaud S; Bongiovanni M; Pache JC; Fioretta G; Robert JH
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):622-6. PubMed ID: 19258078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary resection of non-small cell lung cancer: is survival in the elderly not affected by tumor stage after complete resection?
    Bölükbas S; Beqiri S; Bergmann T; Trainer S; Fisseler-Eckhoff A; Schirren J
    Thorac Cardiovasc Surg; 2008 Dec; 56(8):476-81. PubMed ID: 19012213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the new international TNM staging system for carcinoma of the esophagus as compared with the Chinese trial clinicopathological staging system--an analysis of 224 cases].
    Cheng GY
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):358-61. PubMed ID: 8174481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K; Bonomi M; Packer S; Wisnivesky J
    Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging in untreated patients with small cell lung cancer.
    Vrdoljak E; Mise K; Sapunar D; Rozga A; Marusic M
    Neoplasma; 2001; 48(2):154-6. PubMed ID: 11478698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic assessment of resected lung cancer based on the new international staging system: analysis by histologic types].
    Yokouchi H; Kodama K; Higashiyama M; Takami K
    Kyobu Geka; 2000 Oct; 53(11):899-904. PubMed ID: 11048438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [TNM staging system of lung carcinoma: historical notes, limitations and controversies].
    Motta G; Nahum MA; Testa T; Spinelli E
    Ann Ital Chir; 1995; 66(4):425-32. PubMed ID: 8686992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.